Y-Intercept (HK)’s Edgewise Therapeutics EWTX Stock Holding History

Y-Intercept (HK)’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Buy	+5,466	New	+$188K	﹤0.01%	1538
2026 Q1	–	Sell	-18,672	Closed	-$463K	–	1698
2025 Q4	$463K	Sell	18,672 -38,628	-67%	-$775K	0.01%	1255
2025 Q3	$929K	Buy	+57,300	New	+$813K	0.02%	1010
2024 Q3	–	Sell	-13,701	Closed	-$247K	–	1462
2024 Q2	$247K	Sell	13,701 -1,202	-8%	-$21K	0.01%	1096
2024 Q1	$272K	Buy	+14,903	New	+$237K	0.02%	996

Other funds holding EWTX

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CCMG

Connecticut Capital Management Group Milford, Connecticut $124M AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Eleva Capital Paris, France $343M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Y-Intercept (HK)'s EWTX Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 5,466 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1538 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in EWTX as recently as Q4 2025.

Y-Intercept (HK) first reported a position in EWTX in Q1 2024 and has held it in 5 quarters since. The position peaked at $929K in Q3 2025. 20 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

Y-Intercept (HK) held 5,466 shares of Edgewise Therapeutics worth $222K as of Q2 2026.
Edgewise Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
Edgewise Therapeutics made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1538 holding.
Y-Intercept (HK) first reported a position in Edgewise Therapeutics in Q1 2024 and has held it in 5 quarters since.
Y-Intercept (HK)'s Edgewise Therapeutics position peaked at $929K in Q3 2025.
20 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.